BIOTECHNOLOGY VALUE FUND L P 13D and 13G filings for Verastem, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-13 8:16 pm Purchase | 2022-12-31 | 13G | Verastem, Inc. VSTM | BIOTECHNOLOGY VALUE FUND L P | 1,674,539 9.990% | 132,359 (+8.58%) | Filing |
| 2022-01-10 4:52 pm Purchase | 2022-01-06 | 13G | Verastem, Inc. VSTM | BIOTECHNOLOGY VALUE FUND L P | 1,542,180 10.200% | 120,333 (+8.46%) | Filing |
| 2022-01-10 4:49 pm Purchase | 2021-12-31 | 13G | Verastem, Inc. VSTM | BIOTECHNOLOGY VALUE FUND L P | 1,421,847 9.400% | 490,097 (+52.60%) | Filing |
| 2021-02-11 4:22 pm Purchase | 2020-12-31 | 13G | Verastem, Inc. VSTM | BIOTECHNOLOGY VALUE FUND L P | 931,750 6.600% | 404,333 (+76.66%) | Filing |